IRADIMED CORPORATION (IRMD)

IRADIMED CORPORATION Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	19.23	17.19	12.83	9.33
Depreciation & Amortization	0.82	0.77	0.67	1.41
Loss (Gain) From Sale of Assets	0	0.01	-0	0.01
Loss (Gain) From Sale of Investments	-	-	-0.01	-0.02
Stock-Based Compensation	2.52	2.19	1.39	1.46
Provision & Write-off of Bad Debts	-0.09	0.21	0.1	0.01
Other Operating Activities	-0.61	-0.99	0.11	0.64
Change in Accounts Receivable	1.76	0.84	-8.24	-0.58
Change in Inventory	3.13	-7.47	-1.31	-0.39
Change in Accounts Payable	-0.86	-0.22	1.12	0.03
Change in Unearned Revenue	-0.11	0.62	0.53	0.05
Change in Income Taxes	-0.79	0.25	3.05	-0.83
Change in Other Net Operating Assets	0.62	0.06	-0.21	0.14
Operating Cash Flow	25.62	13.47	10.04	11.26
Operating Cash Flow Growth	90.30%	34.08%	-10.80%	93.52%
Capital Expenditures	-8.01	-7.44	-0.82	-0.48
Sale (Purchase) of Intangibles	-0.81	-0.57	-1.05	-0.26
Investment in Securities	-	-	0.5	1.39
Investing Cash Flow	-8.82	-8.01	-1.37	0.65
Issuance of Common Stock	0.03	0.18	0.15	0.62
Repurchase of Common Stock	-0.69	-0.61	-0.29	-0.6
Common Dividends Paid	-13.68	-13.22	-12.56	-
Financing Cash Flow	-14.34	-13.66	-12.71	0.02
Net Cash Flow	2.47	-8.2	-4.04	11.93
Free Cash Flow	17.62	6.02	9.22	10.78
Free Cash Flow Growth	192.46%	-34.66%	-14.44%	100.50%
Free Cash Flow Margin	24.06%	9.19%	17.30%	25.77%
Free Cash Flow Per Share	1.38	0.47	0.73	0.86
Cash Income Tax Paid	6.51	5.35	1.71	0.97
Levered Free Cash Flow	3.94	8.4	5.89	8.16
Unlevered Free Cash Flow	3.94	8.4	5.89	8.16
Change in Working Capital	3.75	-5.91	-5.06	-1.58

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q